Topic resource collection
Approved comparison material connected to this topic.
1378 resourcesRead both sides
5-Amino-1MQ NNMT inhibition 48–72 hours 4–6 weeks 8–12 weeks Slower onset than receptor agonists but sustained metabolic reprogramming. Better suited for long-duration studies NMN (Nicotinamide Mononucleotide) NAD+ precursor 2–4 …
Epithalon Activates telomerase (TERT), lengthens telomeres, restores pineal melatonin 12-year observational study (N=266): 28% mortality reduction; Phase II trial: 42% telomere lengthening 10 mg daily × 10–20 days, 1–2 cycles/yea…
300 mcg once daily 300 mcg Morning (30 min post-wake) 7–10 days Phase II trials (moderate) Effective for mild generalised anxiety. Requires consistent timing to maintain therapeutic window 300 mcg twice daily 600 mcg Morning + mi…
| Protocol | Dose per Injection | Frequency | Daily Total | GH Pulse Profile | Recovery Application | Professional Assessment ||—|—|—|—|—|—|| Conservative | 100 mcg | 2× daily (morning, pre-bed) | 200 mcg/day | Moderate amplitude…
Epithalon Telomerase activation + pineal regulation 4-8 weeks (immune/hormonal) 10-16 weeks (telomerase) 10-20 days every 4-6 months Slowest onset, deepest structural change. Requires patience and protocol adherence Thymalin Thym…
Hexarelin GHS-R1a agonist (selective) 4–6 weeks (VAT), 10–12 weeks (SAT) 6–10× baseline Minimal at doses ≤400mcg/day Fastest visceral fat mobilization among GH secretagogues, minimal ghrelin-driven appetite increase makes it idea…
GHRP-6 Acetate 20–40 min 90–120 min High (direct GHS-R1a agonist) Moderate pulse at 30–45 min Appetite stimulation, cachexia models, timed feeding protocols GHRP-2 25–45 min 60–90 min Moderate (partial agonist) Strong pulse at 30…
GHRP-2 Acetate Direct GHS-R1a agonist; bypasses leptin signaling 20–40 min 60–90 min 2–4 hours Most predictable onset and dose-response curve; works independent of metabolic state; requires injection GHRP-6 GHS-R1a agonist with h…
Dynamic expression lines. Wrinkles visible only during muscle contraction (frown lines, crow's feet while smiling). Respond to lower Snap-8 concentrations (0.5–2%) because the target is reducing the intensity of the muscle contra…
20–40 minutes (Acute Onset) Enkephalin degradation inhibition; acute GABAergic tone modulation Subjective calming; reduced autonomic arousal (lower heart rate, reduced muscle tension) Acute phase provides immediate relief but is …
Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) respond differently to growth hormone-mediated lipolysis because of receptor density differences. VAT contains approximately 30–50% more beta-adrenergic receptor…
Resting Energy Expenditure Increase Beta-3 adrenergic receptor activation via sustained norepinephrine elevation 7–14 days 6–10% above baseline at steady state (week 3–4) Returns to baseline within 10–14 days post-cessation Measu…
Epithalon is frequently compared to other peptides marketed for sleep support, but the mechanisms differ fundamentally. The table below contrasts clinical data across the most researched compounds. Epithalon Telomerase activation…
GHRP-6 Acetate Ghrelin receptor agonism → GH pulse → IGF-1 elevation → collagen synthesis 12–16 weeks for structural changes; 7–14 days for symptom relief Moderate. Stimulates existing chondrocytes but cannot restore depleted pop…
Typical Dose 300–500 mcg sermorelin once daily 300 mcg sermorelin + 100 mcg GHRP-2 once daily 300 mcg sermorelin + 200 mcg ipamorelin once daily Stacking amplifies GH pulse amplitude but increases cost and injection complexity GH…
This table compares the most studied kisspeptin protocols, their target populations, administration routes, and documented outcomes. Ovulation Induction (Hypothalamic Amenorrhea) Women with functional hypothalamic amenorrhea (HA)…
The landscape of hepatic lipid-modulating therapies ranges from over-the-counter oral supplements to prescription pharmaceuticals. Understanding where LIPO-C fits requires clear comparison across efficacy, mechanism, accessibilit…
GHRP-6 Acetate 20–40 min Moderate GHS-R1a affinity; minimal cortisol/prolactin cross-reactivity Strong ghrelin mimicry increases hunger 60–90 min post-dose Research protocols prioritising clean GH release with controlled feeding …
Before selecting a peptide protocol, understanding how different growth hormone secretagogues compare across selectivity, side effect profiles, and practical dosing helps researchers design studies that align with specific metabo…
Intranasal spray 20–45 minutes 45–60 minutes 2–4 hours 4–6 weeks with daily dosing Most researched route; rapid onset but requires consistent daily administration for mood consolidation Sublingual administration 15–30 minutes 30–…